Riot Platforms, Inc. — Director's Dealing 2010

Jan 21, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AspenBio Pharma, Inc. (APPY)
CIK: 0001167419
Period of Report: 2010-01-19

Reporting Person: WELCH DAVID E (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-01-19	Option - Right to Buy	$2.20	A	50000	Acquired	2020-01-19	Common Stock (50000)	Direct

Footnotes

F1: The option to purchase 50,000 shares of common stock shall become exercisable as to 33.33% of the shares on each of January
19, 2011 and January 19, 2012, and as to the remaining 33.34% of the shares on January 19, 2013.